Related Experiment Video
Updated: Jul 24, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Mechanistic insights into PFOS-induced inflammatory bowel disease: a network toxicology and molecular docking study
Fan Wang1, Baolong Cheng1, Wei Wu1
1Department of Colorectal Surgery, Shanxi Provincial People's Hospital, Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, China.
Objective:
Perfluorooctanesulfonic acid (PFOS), a persistent environmental pollutant, is implicated in immune dysregulation. Rising inflammatory bowel disease (IBD) incidence parallels environmental contamination, yet PFOS's role in gut inflammation remains unclear. Its immunotoxicity may disrupt intestinal homeostasis via barrier dysfunction or cytokine imbalance, but molecular targets and pathways linking PFOS to IBD pathogenesis require elucidation to inform risk mitigation strategies.
Methods:
This study aims to elucidate the mechanism of action of PFOS in the development and progression of IBD. Additionally, relevant PFOS targets and IBD-associated genes were screened using databases such as results indicate that PFOS is significantly associated with key pathways involved in IBD, and it can specifically bind to crucial IBD proteins like albumin, epidermal growth factor, fos proto-oncogene, and interleukin-10.
Results:
The study suggests that PFOS may contribute to the pathogenesis of IBD by interfering with key proteins and signaling pathways, highlighting its potential health risks, and providing a theoretical basis for subsequent clinical research and prevention strategies.
Conclusion:
In conclusion, this study has untangled the potential mechanistic link between PFOS exposure and inflammatory bowel disease, offering a novel perspective for environmental health science and public health policies and profound implications.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019